ECHO trial shows contraception does not increase risk of HIV – Daily Trust

  • 📰 Daily Trust
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Nigeria Headlines News

Nigeria Latest News,Nigeria Headlines

ECHO trial shows contraception does not increase risk of HIV

The evidence, which comes from the highly-publicised Evidence for Contraceptive Options and HIV Outcomes trial, found there was no significant difference in risks of contracting HIV depending on the method of contraception women used.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 13. in NG

Nigeria Latest News, Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Global experts on HIV science call for urgent actions – Daily TrustThe 10th IAS Conference on HIV Science (IAS 2019), kicked off in Mexico with global experts calling for urgent action to address the...
Source: Daily Trust - 🏆 13. / 51 Read more »

WHO recommends dolutegravir as preferred HIV treatment drug – Daily TrustThe World Health Organization (WHO) has strongly recommended the use of the HIV drug, dolutegravir (DTG) as the preferred first-line and second-line treatment for all ages.
Source: Daily Trust - 🏆 13. / 51 Read more »

Osagie unveils HIV/AIDS protest exhibition - The Nation NewspaperThe Nation’s Evelyn Osagie has unveiled an online photo advocacy exhibition, tagged: WETINiSABI.The multimedia exhibition, which seeks to create...
Source: TheNationNews - 🏆 6. / 69 Read more »

Major health stories in the news last week - Premium Times NigeriaHigh rate of HIV in Nigerian prisons and a dire shortage of decent toilets were some of the top news
Source: PremiumTimesng - 🏆 3. / 78 Read more »

Global experts on HIV science call for urgent actions – Daily TrustThe 10th IAS Conference on HIV Science (IAS 2019), kicked off in Mexico with global experts calling for urgent action to address the...
Source: Daily Trust - 🏆 13. / 51 Read more »

WHO recommends dolutegravir as preferred HIV treatment drug – Daily TrustThe World Health Organization (WHO) has strongly recommended the use of the HIV drug, dolutegravir (DTG) as the preferred first-line and second-line treatment for all ages.
Source: Daily Trust - 🏆 13. / 51 Read more »